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Abstract
Summary In this cohort of relatively young and well-treated
participants with type 2 diabetes, we found no association
between diabetes status and a history of previous fractures
and recent falls. Furthermore, no association between diabetes
severity and previous fractures or recent falls was found.
Introduction In this study, we examined the association be-
tween glucose metabolism status and historical fractures or
recent falls and the effect of diabetes severity (glucose control,
insulin use, and diabetes duration) on falls and fractures in the
participants with type 2 diabetes.
Methods Cross-sectional data from 2005 participants of the
Maastricht Study. Falls in the past 6 months and fractures
≥age 50 were assessed by questionnaire. Glucose metabolism
status (normal glucose metabolism, impaired glucose metab-
olism, or type 2 diabetes) was based on the oral glucose tol-
erance test and medication use.
Results In the completely adjusted model, the odds for a fall
were not significantly higher in those with impaired glucose
metabolism status (OR (95%CI) 1.28 (0.93–1.77)) or with
type 2 diabetes (OR (95%CI) 1.21 (0.80–1.81)) compared
with the group with normal glucose metabolism. Within the
group with type 2 diabetes, there were no significant differ-
ences with regard to reported falls between participants with
HbA1c >7 % (53 mmol/mol) versus HbA1c ≤7 % (OR
(95%CI) 1.05 (0.58–1.90)), insulin users versus non-insulin
users (OR (95%CI) 1.51 (0.79–2.89)), and with a diabetes
duration >5 versus ≤5 years (OR (95%CI) 0.52 (0.46–1.47)).
Similarly, neither glucose metabolism status nor diabetes se-
verity was associated with prior fractures.
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Conclusions Glucose metabolism status was not significantly
associated with previous fractures and recent falls. In addition,
in this cohort of relatively young and well-treated participants
with type 2 diabetes, diabetes severity was not associated with
previous fractures and recent falls.
Keywords Diabetes severity . Falls . Fractures . Type 2
diabetesmellitus
Introduction
Falls are a major public health problem that causes consider-
able morbidity and affects the quality of life of people around
the world [1]. Several risk factors for falls, such as age, phys-
ical inactivity, loss of balance, and loss of vision, have been
identified. Due to both complications of their disease and a
direct effect of the disease on bone quality, patients with type 2
diabetes are thought to have an increased fall and fracture risk
[2, 3]. However, conflicting results about fall and fracture risk
in patients with type 2 diabetes have been described.
Compared to subjects with normal glucose metabolism, fall
and fracture risk may be either comparable or increased in
patients with type 2 diabetes [3–10]. These different results
may be explained by differences in the way diabetes has been
diagnosed (self-reported vs. an oral glucose tolerance test
(OGTT)) and how falls and fractures have been reported (ret-
rospective vs. prospective). Furthermore, indicators of diabe-
tes severity such as the degree of glucose control, the duration
of disease, and the prevalence of insulin use are often not
reported. This may have resulted in study populations with
different levels of exposure and, consequently, different re-
sults [4, 5, 7, 8, 10].
Only few studies about fracture risk and no studies about
fall risk in people with impaired glucose metabolism (defined
as either impaired fasting glucose or impaired glucose toler-
ance) have been published. People with impaired glucose me-
tabolism are often overweight, which is associated with a de-
creased fracture risk [11], and have increased serum levels of
insulin [12], which stimulates bone formation. It may there-
fore be hypothesized that people with impaired glucose me-
tabolism have a decreased fracture risk. Previous studies in-
deed showed a normal to decreased fracture risk in people
with impaired glucose metabolism when compared to people
with normal glucose metabolism [6, 12, 13].
In the present study, we examined the association between
glucose metabolism status and recent falls and previous frac-
tures in a well-characterized cohort of participants from the
Maastricht Study aged 50 years and older. Additionally, we
examined the association between glucose control, insulin
use, diabetes duration, and falls in the past 6 months and
fractures at or above the age of 50. We hypothesized that the
prevalence of falls and fractures in participants with impaired
glucose metabolism is similar or decreased when compared to
participants with normal glucose metabolism and that the
prevalence of falls and fractures in participants with type 2
diabetes is increased only in those with inadequately regulated
diabetes, insulin users and those with a long duration of the
disease.
Methods
Study population and design
We used data from the Maastricht Study, an observational pro-
spective population-based cohort study. The rationale and
methodology have been described previously [14]. In brief,
the study focuses on the etiology, pathophysiology, complica-
tions, and comorbidities of type 2 diabetes mellitus and is char-
acterized by an extensive phenotyping approach. Eligible for
participation were all home-dwelling individuals aged between
40 and 75 years and living in the southern part of the
Netherlands. Participants were recruited through mass media
campaigns and from the municipal registries and the regional
Diabetes Patient Registry via mailings. Recruitment was strat-
ified according to known type 2 diabetes status, with an
oversampling of individuals with type 2 diabetes for reasons
of efficiency. The present report includes cross-sectional data
from a subset of the first 3451 participants who completed the
baseline survey between November 2010 and September 2013.
Participants with type 1 diabetes mellitus or another type of
diabetes (n=41) were excluded. Participants aged under 50
(n=457) were excluded because one of our main outcome
measures is a historical fracture at or above the age of 50.
From the remaining 2953 participants, data on falls in the past
6 months was available in 2688 participants and on fractures at
or above the age of 50 in 2463 participants. To examine the
association between type 2 diabetes and falls and fractures only
in participants who already had diabetes at the date of their fall
or fracture, we excluded participants with an unknown duration
of diabetes (n=243 for the fall analysis population and n=209
for the fracture analysis population) and those with an unknown
date of the fracture. For the fall analysis population, we further
excluded participants with type 2 diabetes and a diabetes dura-
tion less than 1 year (n=14), or missing data on covariates
(n=426), leaving 2005 participants for the fall analysis popu-
lation. For the fracture analysis population, we further excluded
type participants with type 2 diabetes who reported a fracture
before being diagnosed with diabetes (n=15), or missing data
on covariates (n=392), leaving 1847 participants for the frac-
ture analysis population (Fig. 1). The examinations of each
participant were performed within a time window of 3 months.
All participants were ambulatory. The study has been approved
by the ins t i tu t iona l medica l e th ica l commi t t ee
(NL31329.068.10) and the Minister of Health, Welfare and
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Sports of the Netherlands, on the basis of the Health Council’s




To determine glucose metabolism status, all participants, ex-
cept those who used insulin, underwent a standardized 2-h
75 g OGTT after an overnight fast. For safety reasons, partic-
ipants with a fasting glucose level >11.0 mmol/L (>200.0 mg/
dl), as determined by a capillary blood glucose measurement,
did not undergo the OGTT. Fasting glucose level, 2-h plasma
glucose level, and information about diabetesmedicationwere
used to determine glucose metabolism status. Glucose metab-
olism was defined according to the WHO 2006 criteria into
normal glucose metabolism (fasting plasma glucose
<6.1 mmol/L (<110.0 mg/dl) and 2-h plasma glucose
<7.8 mmol/L (<140.0 mg/dl) and no diabetes medication),
impaired fasting glucose (fasting plasma glucose 6.1–
6.9 mmol/L (110.0–125.0 mg/dl) and 2-h plasma glucose
<7.8 mmol/L (<140.0 mg/dl) and no diabetes medication),
impaired glucose tolerance (fasting plasma glucose
<7.0 mmol/L (<126.0 mg/dl) and 2-h plasma glucose ≥7.8
and <11.1 mmol/L (≥140.0 and <200.0mg/dl) and no diabetes
medication), and type 2 diabetes (fasting plasma glucose
≥7.0 mmol/L (≥126.0 mg/dl) or 2-h plasma glucose
≥11.1 mmol/L (≥200.0 mg/dl) or diabetes medication) [15].
Individuals without type 1 diabetes who used diabetes medi-
cation were classified as having type 2 diabetes. For this study,
we defined having either impaired fasting glucose or impaired
glucose tolerance as impaired glucose metabolism. Use of
glucose-lowering medication was assessed during a medica-
tion interview where generic name, dose, and frequency were
registered. Diabetes duration was assessed by questionnaire.
HbA1c level was determined as described elsewhere [14].
The group with type 2 diabetes was divided into subgroups
of participants with well-regulated disease (HbA1c ≤7 %
(≤53 mmol/mol)) and with inadequately regulated disease
(HbA1c >7 % (>53 mmol/mol)), in insulin and non-insulin
users; and in participants with a diabetes duration ≤5 years and
>5 years.
Falls and fractures
Using a web-based questionnaire, participants were asked if
they experienced a fall in the past 6 months, and, if so, how
many times they fell in the past 6months. Participants who fell
two or more times in the past 6 months were labeled as recur-
rent fallers. Additionally, participants were asked if they had
ever had a fracture and, if so, which bone(s) and the date(s) of
Fig. 1 Flow chart of patient
selection
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the fracture(s). A fall in the past 6 months and a fracture at or
above the age of 50 were our primary end points.
Covariates
The following covariates were included: age, sex, educational
level, BMI, moderate-to-vigorous physical activity (MVPA),
history of cardiovascular disease (CVD), smoking status, al-
cohol use, use of blood pressure lowering medication, use of
lipid-modifying medication, use of benzodiazepines, depres-
sion, and cognitive performance.
Level of education was assessed by questionnaire and clas-
sified into three categories: low (no education; primary edu-
cation; or lower vocational education), intermediate (interme-
diate general secondary education; intermediate vocational
education; or higher general secondary education), and high
(higher vocational education; or university).
Weight and height were measured without shoes and wear-
ing light clothing using a scale and stadiometer to the nearest
0.5 kg or 0.1 cm (Seca, Hamburg, Germany). BMI was cal-
culated by dividing the weight in kilogram by the height in
centimeters squared.
MVPA, in hours per week, was calculated from the modi-
fied Community Health Activities Model Program for Seniors
(CHAMPS) questionnaire [16]. Activities accounted as
MVPA were fast walking, fast cycling, heavy gardening,
heavy household work, jogging/running, swimming, tennis,
team sport, and intensive exercise.
History of CVD, smoking behavior, and alcohol consump-
tion were assessed by questionnaire. Participants were regarded
as having a history of CVD if they reported to have had a
myocardial infarction and/or cerebrovascular infarction or hem-
orrhage, and/or percutaneous artery angioplasty or vascular sur-
gery on the coronary, abdominal, peripheral or carotid arteries.
Smoking behavior was classified as never, former, and current.
Alcohol consumption was classified into three categories:
non-consumers, low consumers (≤7 glasses per week for
women and ≤14 glasses per week for men), and high con-
sumers (>7 glasses per week for women and >14 glasses per
week for men).
Use of blood pressure lowering medication, lipid-
modifying medication, and sleep medication was assessed
during a medication interview where generic name, dose,
and frequency were registered.
Presence of a depressive disorder in the preceding 2 weeks
was assessed by the Mini International Neuropsychiatric
Interview according to the Diagnostic and Statistical Manual
of Mental Disorders, Fourth Edition (DSM-IV), as described
in detail elsewhere [17].
General cognitive performance was assessed using the
Minimal Mental State Examination (MMSE) [18]. The exam-
ination resulted in a score between 0 and 30, with a score of 24
or less being labeled as impaired cognitive function.
Statistical analysis
All statistical analyses were performed using the Statistical
Package for Social Sciences (version 22.0; IBM, Chicago,
IL, USA). General characteristics of the study population were
compared between the group with normal glucose metabo-
lism, the group with impaired glucose metabolism, and the
group with type 2 diabetes. One-way ANOVA was used to
test for significant differences of continuous variables and a
chi-square test for differences in categorical variables between
the normal glucose metabolism, the impaired glucose metab-
olism, and the type 2 diabetes groups. To examine the associ-
ation between glucose metabolism status and falls or fractures,
and to examine the association between diabetes regulation,
insulin use, or duration of diabetes and falls or fractures, lo-
gistic regression analysis was used, yielding odds ratios (OR)
and 95 % confidence intervals (CI). The same models were
used for all regression analyses; model 1 was an unadjusted
model; model 2 included age, sex, and level of education; and
model 3 was additionally adjusted for BMI, MVPA, a history
of CVD, smoking status, alcohol consumption, the use of
blood pressure lowering medication, the use of lipid-
modifying drugs, the use of sleep medication, depression,
and cognitive function. A p value less than 0.05 was consid-
ered statistically significant. In additional analyses, the asso-
ciation between glucose metabolism status and recurrent falls
was examined, using multinomial logistic regression analysis.
Interactions of sex of the participant with the respective expo-
sure variables of interest (i.e., glucose metabolism status, dia-
betes regulation, insulin use, or duration of diabetes) were
tested for all regression analyses.
Results
General characteristics of the fall analysis population accord-
ing to glucose metabolism status are shown in Table 1. In total,
1246 participants were classified as having normal glucose
metabolism, 359 as having impaired glucose metabolism,
and 400 as having type 2 diabetes. Participants with type 2
diabetes were the oldest, the least likely to be female, had the
lowest level of education, the highest BMI, and the highest
prevalence of depression. Participants with normal glucose
metabolism had the lowest prevalence of CVD and the highest
prevalence of non-smokers. Alcohol consumption was the
lowest in the group with type 2 diabetes. The mean HbA1c
level of the group with type 2 diabetes was 7.0 % (53.4 mmol/
mol); almost 93 % used antidiabetic drugs, including insulin
in 26 %. The median diabetes duration was 7.0 years. The
prevalence of a fall in the past 6 months and the number of
falls in the past 6 months was not significantly different be-
tween the groups, while the prevalence of a fracture at or
above the age of 50 was lowest in the group with type 2
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diabetes. The general characteristics of the fracture analysis
population according to glucose metabolism status were com-
parable to those of the fall analysis population (not tabulated).
Table 2 shows the association between glucose metabolism
status and falls or fractures. The odds ratio (OR) for a fall was
significantly increased in participants with impaired glucose
metabolism (OR (95 % CI) 1.37 (1.01–1.87)) after adjustment
for age, sex, and level of education (model 2). After further
adjustment (model 3) the OR was no longer statistically
significant (OR (95 % CI) 1.28 (0.93–1.77)). The addition of
BMI to model 2 resulted in loss of statistical significance (data
not shown). When the impaired glucose metabolism group
was divided into participants with impaired fasting glucose
and in participants with impaired glucose tolerance, the odds
for a fall was increased only in participants with impaired
glucose tolerance after adjustment for age, sex, and level of
education (model 2, OR (95 % CI) 1.42 (1.01–1.99)). The
odds for a fall in the group with type 2 diabetes was not
Table 1 General characteristics









Age (years) 60.5 (6.1) 63.0 (5.9) 63.4 (6.3) <0.001
Female sex 708 (56.8) 158 (44.0) 128 (32.0) <0.001
Level of education
- Low 344 (27.6) 131 (36.5) 165 (41.3) <0.001
- Medium 324 (26.0) 92 (25.6) 124 (31.0)
- High 578 (46.4) 136 (37.9) 111 (27.8)
BMI (kg/m2) 25.5 (3.6) 27.9 (4.2) 29.7 (4.7) <0.001
Self-reported MVPA (hours/week) 6.2 (4.5) 5.2 (4.2) 4.4 (4.1) <0.001
History of CVD 154 (12.4) 50 (13.9) 120 (30.0) <0.001
Smoking status
- Never 471 (37.8) 103 (28.7) 109 (27.3) <0.001
- Former 645 (51.8) 219 (61.0) 241 (60.3)
- Current 130 (10.4) 37 (10.3) 50 (12.5)
Alcohol consumption category
- None 142 (11.4) 52 (14.5) 114 (28.5) <0.001
- Low 715 (57.4) 194 (54.0) 217 (54.3)
- High 389 (31.2) 113 (31.5) 69 (17.3)
Medication use
- Antidiabetic drugs – – 371 (92.8) –
- Insulin – – 104 (26.0) –
- Blood pressure lowering drugs 303 (24.3) 168 (46.8) 296 (74.0) <0.001
- Lipid-modifying drugs 237 (19.0) 135 (37.6) 315 (78.8) <0.001
- Sleep medication 27 (2.2) 11 (3.1) 9 (2.3) 0.61
Depression 21 (1.7) 9 (2.5) 20 (5.0) 0.001
MMSE score 29.2 (1.1) 28.9 (1.2) 28.7 (1.4) <0.001
HbA1c (%) 5.5 (0.3) 5.7 (0.4) 7.0 (1.1) <0.001
HbA1c (mmol/mol) 36.4 (3.7) 39.0 (4.4) 53.4 (11.5) <0.001
Duration of diabetes in years, mean (IQR) – – 7.0 (9.0) –
Fall in the past 6 months 204 (16.4) 72 (20.1) 66 (16.5) 0.25
Number of falls in the past 6 months
- 0 1042 (83.6) 287 (79.9) 334 (83.5) 0.44
- 1 134 (10.8) 51 (14.2) 42 (10.5)
- ≥2 70 (5.6) 21 (5.8) 24 (6.0)
Fracture ≥50 years of age 119 (10.3) 40 (12.3) 19 (5.4) 0.006
Continues variables are presented as mean (SD) unless otherwise stated, categorical variables as number of
participants (%)
BMI body mass index, CVD cardiovascular disease, IGM impaired glucose metabolism, IQR Interquartile range
MVPA moderate-to-vigorous physical activity, NGM normal glucose metabolism, SD standard deviation, T2DM
type 2 diabetes
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statistically significantly different from those with a normal
glucose metabolism in all models.
The odds for a fracture in the group with impaired
glucose metabolism were not statistically significantly dif-
ferent from those with a normal glucose metabolism in all
models. The odds for a fracture were significantly de-
creased in participants with type 2 diabetes after adjust-
ment for age, sex, and level of education (model 2, OR
(95 % CI) 0.55 (0.32–0.92)), when compared to partici-
pants with normal glucose metabolism. The association
was not significantly different anymore after further ad-
justment for BMI, MVPA, a history of CVD, smoking
status, alcohol consumption, the use of blood pressure
lowering drugs, lipid-modifying drugs, and sleep medica-
tion, and depression and cognitive function (model 3, OR
(95 % CI) 0.70 (0.38–1.27)).
Table 3 shows the association between diabetes regulation,
insulin use, or diabetes duration and falls or fractures in the
group with type 2 diabetes. The mean HbA1c level of the
subgroup with an HbA1c >7 % (>53 mmol/mol) was 8.0
± 1.0 % (64.4±11.4 mmol/mol); the mean HbA1c level of
the subgroup with an HbA1c ≤7 % (≤53 mmol/mol) was
6.4± 0.4 % (46.9±4.3 mmol/mol). The median duration of
diabetes of the subgroup with a diabetes duration >5 years
was 11.0 (interquartile range (IQR) 8.0) years, and of the
subgroup with a diabetes duration ≤5 years was 3.0 (IQR
2.0) years. The OR for a fall of participants with an HbA1c
>7 % (53 mmol/mol), insulin users, or participants with a
diabetes duration of more than 5 years was not statistically
significantly different from those of participants with an
HbA1c ≤7 % (53 mmol/mol), non-insulin users, and those
with a duration of 5 years or less, respectively, in all the
models. Similarly, there were no statistically significant asso-
ciations between HbA1c, insulin use, or diabetes duration and
fractures.
In additional analyses, we examined the association be-
tween glucose metabolism status and recurrent falls (data not
tabulated). Impaired glucose metabolism and type 2 diabetes
were not statistically significantly associated with recurrent
falls. Finally, the results of the regression analyses for a fall
in the past 6 months or recurrent falls in the past 6 months
were similar to those described above, when the fracture anal-
ysis population instead of the fall analysis population was
used.
Discussion
In this study, we examined the association between glucose
metabolism status and a history of fractures and recent falls in
a group of 2005 participants at or above the age of 50 from the
Maastricht Study. In contrast to our hypothesis, we did not
find a significant association between glucose metabolism sta-
tus and a history of falls or fractures. Diabetes severity, in
terms of inadequately regulated disease, insulin use, or dura-
tion of diabetes, was also not significantly associated with
increased odds of prior fractures or recent falls.
Table 2 The association between
glucose metabolism status and
falls in the past 6 months or















NGM 204 1246 Ref Ref Ref
IGM 72 359 1.28 (0.95–1.73) 1.37 (1.01–1.87) 1.28 (0.93–1.77)
- IFG 16 93 1.06 (0.61–1.86) 1.25 (0.71–2.20) 1.16 (0.65–2.07)
- IGT 56 266 1.36 (0.98–1.90) 1.42 (1.01–1.99) 1.32 (0.93–1.89)
T2DM 66 400 1.01 (0.75–1.37) 1.17 (0.85–1.62) 0.95 (0.64–1.40)
Fractures
NGM 119 1162 Ref Ref Ref
IGM 40 326 1.23 (0.84–1.80) 1.20 (0.80–1.78) 1.28 (0.84–1.95)
- IFG 9 85 1.04 (0.51–2.13) 1.24 (0.59–2.58) 1.30 (0.62–2.76)
- IGT 31 241 1.29 (0.85–1.97) 1.19 (0.76–1.85) 1.28 (0.81–2.02)
T2DM 19 359 0.49 (0.30–0.81) 0.55 (0.32–0.92) 0.70 (0.38–1.27)
Model 1: unadjusted, model 2: adjusted for age, sex, and level of education, model 3: model 2 + BMI, MVPA, a
history of CVD, smoking status, alcohol consumption, the use of blood pressure lowering drugs, the use of lipid-
modifying drugs, the use of sleep medication, depression, and cognitive function. NGM is the reference category
CI confidence interval, IGM impaired glucose metabolism, NGM normal glucose metabolism, OR odds ratio,
T2DM type 2 diabetes mellitus
Statistically significant results are presented in italic
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Previous cross-sectional fall studies showed no signif-
icant difference in fall rate between participants with and
without type 2 diabetes [9, 19]. However, both studies
used a small sample size and only showed results of uni-
variate analyses. The results of previous prospective stud-
ies on fall risk in patients with type 2 diabetes are con-
flicting; some studies showed an increased fall risk [8, 10,
20, 21], while others showed a fall risk similar to partic-
ipants without diabetes [7, 13].
Our study is in line with two out of three previous
cross-sectional studies that investigated the association
between type 2 diabetes and fractures, where significant
association between type 2 diabetes and all types of frac-
tures and hip fractures specifically was showed [4, 6].
Additionally, no association between an impaired fasting
glucose and fractures was shown [6]. In contrast, two
meta-analyses and a recent large prospective study
showed an increased fracture risk in patients with type 2
diabetes [3, 22, 23]. However, none of the prospective fall
and fracture studies provided information on HbA1c
levels, the percentage of insulin users, and the duration
of diabetes. This lack of information hampers the compar-
ison of these studies, since they may have been conducted
in patient populations with different characteristics re-
garding type 2 diabetes.
In our study, participants with type 2 diabetes had gen-
erally well-regulated diabetes (mean HbA1c level 7.0 %
(53.4 mmol/mol)), a relatively short median duration of
the disease (7.0 years), and the percentage of insulin users
was low (26.0 %). A potential explanation for the non-
significant differences in fall and fracture rate between
those with and without type 2 diabetes is that an increased
fall and fracture risk is only present in patients with more
severe and longer duration of the disease. Indeed, several
prospective cohort studies showed that only inadequately
regulated diabetes was associated with an increased fall
and fracture risk [13, 24, 25]. In the current, study we did
not find statistically significant differences in the odds of
falls and fractures in inadequately versus adequately reg-
ulated participants with type 2 diabetes, in those with a
Table 3 The association between
diabetes regulation, insulin use, or
















HbA1c ≤7 % (53
mmol/mol)
41 250 Ref Ref Ref








Insulin − 44 296 Ref Ref Ref





























Insulin − 13 269 Ref Ref Ref

















Model 1: unadjusted, model 2: adjusted for age, sex, and level of education, model 3: model 2 + BMI, MVPA, a
history of CVD, smoking status, alcohol consumption, the use of blood pressure lowering drugs, the use of lipid-
modifying drugs, the use of sleep medication, depression, and cognitive function. HbA1c ≤7 % (53 mmol/mol),
insulin, and duration of diabetes ≤5 years are the reference categories
CI confidence interval, OR odds ratio
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duration of diabetes >5 years versus ≤5 years, nor be-
tween insulin users versus non-insulin users. The cut-off
values for HbA1c level and duration of diabetes we chose
can be discussed. We used an HbA1c level of 7 %
(53 mmol/mol) as cut-off value because this is the target
value for diabetes treatment [26]. The mean HbA1c level
of our inadequately regulated group was 8.0 %
(64.4 mmol/mol), which is close to the target value and
may explain the absence of the different fall and fracture
rates between the group with adequately and inadequately
regulated diabetes. Only few patients in our cohort of
patients with type 2 diabetes had HbA1c levels above
9 %; it was therefore not possible to examine the associ-
ation between different degrees of glucose metabolism
regulation and falls or fractures.
The absolute number of fractures in both of our
groups of participants with an impaired glucose metabo-
lism and of participants with type 2 diabetes was very
low (n= 40 and n= 19, respectively), which is remarkable
given the large number of participants in each group and
the fact that quite a high number of participants reported
at least one fall in the previous 6 months (N= 66 and
N= 56, respectively). Due to this low absolute number
of total fractures, there may be a power problem for
showing an association between glucose metabolism sta-
tus and fractures.
The meta-analysis by Janghorbani et al. showed an in-
creased hip fracture risk, but no association between type 2
diabetes and fractures of the distal forearm, proximal humer-
us, or vertebra [22]. In contrast, the meta-analysis by
Vestergaard et al. showed an increase in wrist fracture risk,
but not in non-vertebral and spine fracture risk [3]. Because of
the low absolute number of fractures observed in our study, we
were not able to examine specific types of fractures.
To the best of our knowledge, up to this date, no studies
have been performed on the association between impaired
glucose metabolism and falls. Fracture risk has previously
been shown to be normal or decreased in participants with
impaired glucose metabolism [6, 12, 13]. Because most frac-
tures occur due to a fall [27], a normal to decreased fall risk
may be expected. On the other hand, our participants with
impaired glucose metabolism were less physically active than
participants with normal glucose metabolism and this may
lead to some degree of muscle weakness in participants with
impaired glucose metabolism and therefore an increased fall
risk. Furthermore, the BMI of our participants with impaired
glucose metabolism was significantly higher than the BMI of
participants with normal glucose metabolism, which could
also contribute to an increased falling frequency [28]. In our
study, we found a significant association between impaired
glucose metabolism and a fall in the past 6 months after ad-
justment for demographic factors. The association became
non-significant after adjustment for BMI and other
confounders, so the increased odds of fall in participants with
an impaired glucose metabolism in model 2 may be partly
explained by their increased BMI. No statistically significant
association between participants with impaired glucose me-
tabolism and fractures was found.
Strengths of this study include the objective determi-
nation of the glucose metabolism status in a large study
population, the well-characterized study cohort, and the
availability of extensive information about our partici-
pants with type 2 diabetes. In contrast to many previous
studies, glucose metabolism status was determined with
an OGTT, which allowed us to compare distinct groups
of participants. Information about insulin use, an objec-
tively determined HbA1c level, and the duration of di-
abetes was well registered for all participants with type
2 diabetes which enabled us to compare different sub-
groups of participants with type 2 diabetes.
Limitations of our study include the absence of a definition
of ‘fall’ in our questionnaire, the cross-sectional study design,
the use of retrospectively collected and self-reported data on
falls and fractures, and the lack of information about compli-
cations of diabetes. According to the PROFANE guideline
[29], a fall should be defined as Ban unexpected event in which
the participants come to rest on the ground, floor, or lower
level.^ Due to the absence of this definition, participants
may have either reported a fall that did not meet the definition
or not reported a fall that did meet the definition. Prospective
collection of data on falls using a fall diary and on fractures
using radiology rapports is preferable over the use of self-
reported falls and fractures. However, previous research
showed that the accuracy of both self-reported falls and frac-
tures is reasonable [30–32]. Because data about falls and frac-
tures were collected retrospectively, it is not possible to assess
whether participants labeled as having impaired glucose me-
tabolism already had impaired glucose metabolism at the mo-
ment of their fall or fracture. Because we wanted to be sure to
examine the association between type 2 diabetes and falls and
fractures only in participants who already had diabetes at the
date of their fall or fracture, we excluded participants with an
unknown duration of diabetes and those with an unknown
date of the fracture. This may have contributed to the low
absolute number of fractures that were left for our analyses.
In our study, we used HbA1c level, insulin use, and diabetes
duration instead of complications of diabetes as markers of
diabetes severity. Future studies are needed to study the asso-
ciation between complications of diabetes and falls and
fractures.
In conclusion, glucose metabolism status was not signifi-
cantly associated with a history of fractures or recent falls.
Furthermore, diabetes severity was also not significantly as-
sociated with prior fractures or recent falls. This study sug-
gests that the fall and fracture rate may not be increased in
relatively young patients with generally well-regulated type 2
3214 Osteoporos Int (2016) 27:3207–3216
diabetes. Prospective cohort studies with an extensively de-
scribed type 2 diabetes cohort should be performed to confirm
these results.
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